Metabolic syndrome and the risk of ischemic heart disease and stroke among middle-aged Japanese

Hypertension Research

Volumn 31, Issue 10, 2008, Pages 1887-1894

  Chei, Choy Lye ^a   Yamagishi, Kazumasa ^a   Tanigawa, Takeshi ^a,b   Kitamura, Akihiko ^c   Imano, Hironori ^c   Kiyama, Masahiko ^c   Sato, Shinichi ^d   Iso, Hiroyasu ^e  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d CHIBA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTION; SEX DIFFERENCE; ASIAN; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; ETHNOLOGY; HEART MUSCLE ISCHEMIA; JAPAN; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX RATIO; STATISTICS; STROKE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; STROKE;

EID: 58149380170     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1887     Document Type: Article

References (34)

1. Earl SF: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 2005; 28: 1769-1778.
2. Lorenzo C, Williams K, Hunt KJ, Haffner SM: Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence. Diabetes Care 2006; 29: 625-630.
3. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PWF: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380-385.
4. Malik S, Wong ND, Franklin SS, et al: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
5. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP: National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004; 110: 1251-1257.
6. Lakka H-M, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
7. Frod ES: The metabolic syndrome and mortality from cardiovascular disease and all causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173: 309-314.
8. Guzder RN, Gatling W, Mullee MA, Bryne CD: Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2006; 49: 49-55.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
10. Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
11. Alberti KGMM, Zimmet P, Shaw J: Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetes Care 2006; 23: 469-480.
12. Definition and diagnosis criteria of metabolic syndrome - Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nippon Naika Gakkai Zasshi 2005; 94: 794-809 (in Japanese).
13. Iso H, Sato S, Kitamura A, et al: Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007; 38: 1744-1751.
14. Sone H, Mizuno S, Fuji H, et al: Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Diabetes Care 2005; 8: 1463-1471.
15. Sone H, Tanaka S, Ishibashi S, et al: The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions. Diabetes Care 2006; 29: 145-147.
16. Ninomiya T, Kubo M, Doi Y, et al: Impact of metabolic syndrome in the development of cardiovascular disease in a general Japanese population: The Hisayama Study. Stroke 2007; 38: 2063-2069.
17. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT: Metabolic syndrome as a risk factor for coronary heart disease and stroke: An 11 year prospective cohort in Taiwan community. Atherosclerosis 2007; 194: 214-221.
18. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH: Influnce of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 2006; 37: 1060-1064.
19. Shimamoto T, Iso H, Tanigawa T, et al: Stroke, ischemic heart disease and their risk factors in Kyowa town, Ibaraki, Japan. Cardioangiology 2000; 48: 127-133 (in Japanese).
20. WHO Expert Committee: Arterial Hypertension and Ischemic Heart Disease, Preventive Aspect (WHO technical report series No. 231). Geneva, World Health Organization, 1962.
21. Shimamoto T, Komachi Y, Inada H, et al: Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-515.
22. Iso H, Rexrode K, Hennekens CH, Manson JE: Application of computer tomography-oriented criteria for stroke subtype classification in a prospective study. Ann Epidemiol 2000; 10: 81-87.
23. Nakamura M, Sato S, Shimamoto T: Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US cholesterol reference method laboratory network. J Atheroscler Thromb 2003; 10: 145-153.
24. World Health Organization Western Pacific Region, International Association for the Study of Obesity and the International Obesity Task Force: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Health Communication Australia Pty Limited, 2000, p 20.
25. Rockhill B, Newman B, Weinberg C: Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-19.
26. Greenland S: Re: "ConfidInce limits made easy: interval estimation using a substitution method." Am J Epidemiol 1999; 149: 884-886.
27. Kadota A, Hozawa A, Okamura T, et al, NIPPON DATA Research Group: Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care 2007; 30: 1533-1538.
28. Takeuchi H, Saitoh S, Takagi T, et al: Metabolic syndrome and cardiac disease in Japanese men: Applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men.The Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203-208.
29. Yoon YS, Lee ES, Park C, Lee S, Oh SW: The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: The Korea NHANES Study. Int J Obes 2007; 31: 528-534.
30. Tong PC, Ozaki R, Kong AP, et al: The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1206-1211.
31. Nilsson PM, Engstrom G, Hedblad B: The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects - a population-based study comparing three different definitions. Diabet Med 2007; 24: 464-472.
32. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN: The importance of waist circumference in the definition of metabolic syndrome. Diabetes Care 2006; 29: 404-409.
33. Yasuda T, Matsuhisa M, Fujiki N, et al: Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome? Endocr J 2007; 54: 695-702.
34. Iso H, Naito Y, Sato S, et al: Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 2001; 153: 490-499.